These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 16313899
1. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons. Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A. Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899 [Abstract] [Full Text] [Related]
2. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A. J Pharmacol Exp Ther; 2003 Aug 19; 306(2):772-7. PubMed ID: 12734391 [Abstract] [Full Text] [Related]
3. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A. J Neurosci Res; 2008 Dec 19; 86(16):3575-83. PubMed ID: 18655200 [Abstract] [Full Text] [Related]
4. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, Akaike A. Neuropharmacology; 2006 Sep 19; 51(3):474-86. PubMed ID: 16762377 [Abstract] [Full Text] [Related]
6. Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity. Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Niidome T, Sugimoto H, Fujii T, Okabe S, Akaike A. Eur J Pharmacol; 2006 Nov 07; 549(1-3):19-26. PubMed ID: 16996497 [Abstract] [Full Text] [Related]
7. Preclinical evidence of neuroprotection by cholinesterase inhibitors. Akaike A. Alzheimer Dis Assoc Disord; 2006 Nov 07; 20(2 Suppl 1):S8-11. PubMed ID: 16772755 [Abstract] [Full Text] [Related]
8. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease]. Takatori Y. Yakugaku Zasshi; 2006 Aug 07; 126(8):607-16. PubMed ID: 16880719 [Abstract] [Full Text] [Related]
9. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity. Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S. Biochem Biophys Res Commun; 2004 Dec 17; 325(3):976-82. PubMed ID: 15541385 [Abstract] [Full Text] [Related]
10. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity. Akasofu S, Kimura M, Kosasa T, Ogura H, Sawada K. Eur J Pharmacol; 2006 Jan 20; 530(3):215-22. PubMed ID: 16406045 [Abstract] [Full Text] [Related]
11. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, Sugimoto H, Akaike A. Biol Pharm Bull; 2009 Mar 20; 32(3):318-24. PubMed ID: 19252271 [Abstract] [Full Text] [Related]
12. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Liang YQ, Tang XC. Neurosci Lett; 2004 May 06; 361(1-3):56-9. PubMed ID: 15135892 [Abstract] [Full Text] [Related]
13. Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons. Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T. J Pharmacol Exp Ther; 2005 Oct 06; 315(1):125-35. PubMed ID: 15951396 [Abstract] [Full Text] [Related]
14. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. Caricati-Neto A, D'angelo LC, Reuter H, Hyppolito Jurkiewicz N, Garcia AG, Jurkiewicz A. Eur J Pharmacol; 2004 Oct 25; 503(1-3):191-201. PubMed ID: 15496314 [Abstract] [Full Text] [Related]
15. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII. Steiner RC, Heath CJ, Picciotto MR. J Neurochem; 2007 Oct 25; 103(2):666-78. PubMed ID: 17666046 [Abstract] [Full Text] [Related]
16. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death. Noh MY, Koh SH, Kim Y, Kim HY, Cho GW, Kim SH. J Neurochem; 2009 Mar 25; 108(5):1116-25. PubMed ID: 19077054 [Abstract] [Full Text] [Related]
17. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, Lübbert H, Albuquerque EX, Maelicke A. J Pharmacol Exp Ther; 2003 Jun 25; 305(3):1024-36. PubMed ID: 12649296 [Abstract] [Full Text] [Related]
18. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Xiu J, Nordberg A, Zhang JT, Guan ZZ. Neurochem Int; 2005 Sep 25; 47(4):281-90. PubMed ID: 15955596 [Abstract] [Full Text] [Related]
19. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release. Dajas-Bailador FA, Heimala K, Wonnacott S. Mol Pharmacol; 2003 Nov 25; 64(5):1217-26. PubMed ID: 14573772 [Abstract] [Full Text] [Related]
20. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG. J Pharmacol Exp Ther; 2005 Dec 25; 315(3):1346-53. PubMed ID: 16144975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]